Caoimhe (@CNAT86) header
Caoimhe (@CNAT86) profile picture

Caoimhe

@CNAT86

Science, food & business • Lonrú Consulting • Founder of @SculleryMade

 Ireland
linkedin.com/profile/view?id=182991079
Joined July 2009
  • Tweets710
  • Following387
  • Followers120
35Media
Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)Photo by Caoimhe (@CNAT86)
What an amazing experience ringing the @Nasdaq closing bell! Thank you to our employees and partners for helping make this incredible milestone happen!
Image from MaxCyte, Inc. (@MaxCyte_info)
Image from MaxCyte, Inc. (@MaxCyte_info)
2
5
2
18
MaxCyte is excited to take part in today’s @Nasdaq closing bell ceremony! At 3:50pm ET head over to Nasdaq’s livestream to view our leadership team ring the closing bell: ow.ly/Cgvo50Gh14d.
Image from MaxCyte, Inc. (@MaxCyte_info)
2
4
2
19
Starting a PhD soon? Download this easy to use thesis planner (free). You can map out the major phases of your #PhD. Then bring it along to a meeting with your supervisor and discuss if realistic. buff.ly/2NMM78T #PhDchat #ECRchat #postdoc #research #PhDforum
Image from Hugh Kearns (@ithinkwellHugh)
Image from Hugh Kearns (@ithinkwellHugh)
19
147
14
538
Join us for a webinar Apr 7 that will showcase the development of a genome-wide #CRISPR screen in primary #Tcells to identify drug targets for immune-mediated inflammatory diseases (#IMIDs). Preliminary data obtained from a mini screen will be discussed. ow.ly/RTDr50E5BfZ
Image from MaxCyte, Inc. (@MaxCyte_info)
2
6
Congratulations to our partner, @SangamoTx, on the Orphan Designation for BIVV003 for the treatment of #sicklecelldisease: ow.ly/ytDJ50E5dJJ via @GENbio. @sanofi @EMA_News #celltherapy #SCD
Sangamo, Sanofi Show Positive Early Data for SCD Gene-Edited Cell Therapy

Sangamo, Sanofi Show Positive Early Data for SCD Gene-Edited Cell Therapy

An ex vivo gene-edited cell therapy for sickle cell disease (SCD) being developed by Sangamo Therapeutics and Sanofi has generated positive early Phase I/II results in three patients—data that...

genengnews.com
8
2
29
Caoimhe retweeted
ASGCT (@ASGCTherapy) profile picture
ASGCT
@ASGCTherapy3 Mar 2021
#Sicklecell disease occurs when a person inherits a faulty beta-globin gene. Learn more about #genetherapy and #geneediting approaches to treat #SCD: bit.ly/39cHSMZ #bleedingdisordersawarenessmonth
Image from ASGCT (@ASGCTherapy)
7
9
We recognize #RareDiseaseDay as a way to raise awareness about rare conditions, celebrate our research, treatment, and cures progress, and show our support for the need for continued research. @RareDiseases #RareIsMany #ShowYourStripes
Image from MaxCyte, Inc. (@MaxCyte_info)
3
7
Is í Aimee Mackin ó Ard Mhaca imreoir sinsir na bliana @TG4TV Comhghairdeas leat @aimee_mackin agus le @ArmaghLGFA @AIGIreland @ladiesfootball #ProperFan #EffortisEqual
Image from Spórt TG4 (@SportTG4)
3
9
3
174
MaxCyte's Doug Doerfler, President & CEO, and Amanda Murphy, CFO, will present a corporate overview at the Cowen Annual Health Care Conference on March 1 from 1:20 – 1:50 p.m. ET. ow.ly/EGvt50DKHQF
Image from MaxCyte, Inc. (@MaxCyte_info)
2
8
Mark your calendar for March 10 to learn about MaxCyte’s easy, scalable and cGMP-compliant #electroporation platform for #CellTherapy & #ProteinProduction applications at @MyABRF's Annual Meeting: abrf.org/abrf-events. #MyExpertPlatform #ABRF2021 #SilverSponsor
Image from MaxCyte, Inc. (@MaxCyte_info)
3
5
🆕 Calling all data-focussed biotech start-ups. The @SteBioCat DATA accelerator programme can provide you with training and mentoring, helping develop the ideas and skills to move to the next phase. Open for applications now bit.ly/2Zm7Hpy #SBCAccelerator #Biotech
Image from BioIndustry Association (BIA) (@BIA_UK)
1
2
On #WorldCancerDay we are recognising the work of our 2021 Charity Partner @OvarianCancerUK who are doing vital work to raise awareness and find treatments for ovarian #cancer.
Image from BioIndustry Association (BIA) (@BIA_UK)
1
1
1
8
Sé do bheatha - welcome to this page dedicated to Gaelg na hOirialla/ Oriel Irish. I aim to highlight the language once spoken in southeast Ulster/north Leinster which unfortunately came to its demise in the early 20th C, with Ó Meith/Omeath being the last surviving Gaeltacht!
4
31
5
153
Yesterday the number of people vaccinated ,105 million, exceeded the number of people with Covid, 103 million , for first time ever.👍
47
365
46
4,595
The place was miserable & empty so we filled it with replacement customers🐼🐼
Image from La Cucina (@italianfoodie)
Image from La Cucina (@italianfoodie)
Image from La Cucina (@italianfoodie)
Image from La Cucina (@italianfoodie)
64
259
67
3,399
Ok guys, this is how it works: #stbrigidsday #gaeliccalendar #thisistheonlywaythatmakessense
Image from Tim Mc Inerney (@TimMacAndErny)
6
10
6
48
Caoimhe retweeted
TG4 (@TG4TV) profile picture
TG4
@TG4TV25 Jan 2021
🎶Téir abhaile riú, téir abhaile riú Téir abhaile riú Mhearai Téir abhail gus fan sa bhaile... #CovidIreland 💚
2
6
1
38
MaxCyte provides our patented #CellEngineering platform to partners engaged in #DrugDiscovery & development, #Biomanufacturing & #CellTherapy, including #GeneEditing & #ImmunoOncology. Our experts help optimize your products and solve challenges: maxcyte.com.
Image from MaxCyte, Inc. (@MaxCyte_info)
3
8
* Cell-based immuno-oncology dominates cell therapy * #Geneediting advances in the clinic * Reaching new #iPSC milestones ARM’s State of the Industry discusses progress in the #regenmed sector in 2020, & what it means for patients moving forward. The future of medicine is now!
Image from Alliance for Regenerative Medicine (ARM) (@alliancerm)
5
5
Congratulations to our partner, @AllogeneTx, on receiving IND clearance for study ALLO-715.
Allogene Therapeutics (@AllogeneTx) profile pictureAllogene Therapeutics@AllogeneTx23 Dec 2020
Today we received clearance for our IND from the @US_FDA to study our BCMA-targeted #AlloCART #celltherapy in combination with @SpringWorksTx’s gamma secretase inhibitor in patients with relapsed/refractory multiple myeloma. Looking forward to initiating in Q1 2021. #mmsm $ALLO

4
14
Load more